AVLSA

Atlas Venture Life Science Advisors Portfolio holdings

AUM $662M
1-Year Est. Return 6.63%
This Quarter Est. Return
1 Year Est. Return
+6.63%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$739M
AUM Growth
-$91.7M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
17
New
Increased
Reduced
Closed

Top Buys

1
+$536K
2
+$438K
3
+$250K
4
DYN icon
Dyne Therapeutics
DYN
+$184K
5
TECX
Tectonic Therapeutic
TECX
+$20.5K

Top Sells

1
+$3.79M
2
+$3.75M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$174M 23.5%
5,858,262
-126,474
2
$114M 15.42%
9,885,449
+15,966
3
$102M 13.77%
7,608,394
+40,077
4
$73.4M 9.93%
3,461,784
5
$57.1M 7.74%
5,836,874
6
$44.9M 6.08%
10,907,859
7
$41.1M 5.57%
58,264
+621
8
$37.1M 5.02%
2,098,300
9
$35.6M 4.82%
827,948
+60
10
$22.7M 3.08%
594,251
11
$17.3M 2.34%
418,182
12
$8.75M 1.18%
2,759,344
13
$4.54M 0.61%
378,448
+1,709
14
$3.01M 0.41%
236,981
+19,697
15
$2.29M 0.31%
90,072
16
$1.5M 0.2%
1,031,160
17
– –
-599,524